4.7 Review

Mild stimulation for in vitro fertilization

期刊

FERTILITY AND STERILITY
卷 108, 期 4, 页码 558-567

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2017.08.022

关键词

Conventional stimulation; in vitro fertilization; mild stimulation; minimal stimulation

资金

  1. Actavis/Watson/Uteron
  2. Controversies in Obstetrics Gynecology
  3. Dutch Heart Foundation
  4. Dutch Medical Research Council
  5. Euroscreen/Ogeda
  6. Ferring
  7. London Womens Clinic
  8. Merck Serono
  9. Netherland Genomic Initiative
  10. OvaScience
  11. Pantharei Bioscience
  12. PregLem/Gedeon Richter/Finox
  13. Reproductive Biomedicine Online
  14. Roche
  15. Teva
  16. World Health Organization

向作者/读者索取更多资源

It has been proven that the use of high gonadotropin dose does not necessarily improve the final outcome of IVF. Mild ovarian stimulation is based on the principle of optimal utilization of competent oocytes/embryos and endometrial receptivity. There is growing evidence that the pregnancy or live birth rates with mild-stimulation protocols are comparable to those with conventional IVF; the cumulative pregnancy outcome has been shown to be no different, despite having fewer numbers of oocytes or embryos available with milder ovarian stimulation. Although equally effective, mild-stimulation IVF is associated with a greater safety profile, in terms of the incidence of ovarian hyperstimulation syndrome and venous thromboembolism. It is also found to be better tolerated by patients and less expensive. Emerging research evidence may lead to widespread acceptance of mild IVF, by both patients and IVF providers, and make IVF more accessible to women and couples worldwide. (C) 2017 by American Society for Reproductive Medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据